China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 396 participants.
Also called NCT03532620
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 396 participants
- Sponsor
- Registry
-
NCT03532620
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03532620. Randomized; no masking; primary purpose treatment. Start 2018-08-09 (actual); primary completion 2019-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- China Protection Trial of Glucose Metabolism by Pitavastatin in Patients With Prediabetes and Hypertension
- Acronym
- CAMPUS
- Condition
- Prediabetic State
- Condition
- Hypertension
- Condition
- Dyslipidemias
- Intervention (Drug)
- Pitavastatin Calcium
- Intervention (Drug)
- Atorvastatin Calcium
- Lead sponsor
- Jun Tao
- Collaborator
- Sun Yat-sen University
Record details
- Record id
cardio:ct-nct03532620- Content hash
19b8681bbfcafa9e01c930331484da17b446b4a236785f75b390bd5d93f4f1ee